Pharmaceutical

BeOne(BeiGene) Q2 2025 Interim Financial Report BeiGene BeOne Financial statements Chinese Pharmaceutical Market BeiGene reported a net profit of 450 million yuan for H1 2025, marking its first interim profit since A-share listing. Strong product sales and revised revenue and margin forecasts signal sustainable growth.
2025 H1 Global Pharma Earnings Panorama Financial statements Market Trend Novartis Novo Nordisk Sanofi AstraZeneca A comprehensive analysis of global pharma earnings in H1 2025, highlighting innovation-driven growth, key players like Novartis, Novo Nordisk, AstraZeneca, Sanofi, and BeiGene, and trends shaping the industry’s future.
Eli Lilly 2025 H1 Report Financial statements Eli Lilly Eli Lilly's 2025 H1 revenue surged 41% to $28.29B, driven by tirzepatide sales hitting $14.7B. Mounjaro and Zepbound shine as blockbuster drugs, boosting Lilly's global pharmaceutical ranking.
Novo Nordisk H1 2025 Financial Reports Financial statements Novo Nordisk Semaglutide Novo Nordisk's Semaglutide generated $16.7B in H1 2025, surpassing Keytruda as the world's top-selling drug. Strong global and China sales drive growth despite competitive challenges.
Global Biopharma Layoffs August 2025 Layoffs Layoff Merck Moderna Bayer Pfizer The biopharmaceutical industry sees major August layoffs, with companies like Moderna, Merck cutting jobs amid restructurings, trial setbacks, and M&A activity.
Pfizer 2025 H1 Report Financial statements Pfizer Pfizer reported $28.4B in revenue for H1 2025, driven by $1.5B in ADC product sales and strong oncology growth. With $13B in BD firepower, Pfizer eyes long-term expansion across key therapeutic areas.
Small RNA Giant 2025 H1: RNAi Products Sold 8.2 Billion! Alnylam Pharmaceuticals Financial statements Alnylam reports strong 2025 H1 results with $1.14B in RNAi drug sales, up 47% YoY. AMVUTTRA drives growth; stock jumps 15% as market cap surpasses $50B. Pipeline advances in Alzheimer’s, diabetes, and hypertension.
Original Drugs? Generic Drugs? Patent Drugs? Explained in One Article Original Drugs Generic Drugs Patent Drugs Market Trend Learn the key differences between patent, original, and generic drugs. Understand their development, pricing, quality, and how to choose the right medication for safety, affordability, and effectiveness.
AbbVie's Bold Claim: To Become the Largest CNS Company Next Year! AbbVie Market Trend AbbVie sets its sights on becoming the top CNS company by 2026, driven by strong H1 growth, strategic acquisitions, and breakthrough treatments in neuroscience, including schizophrenia, migraine, and Parkinson’s disease.
Pfizer Secures Global Rights to SSGJ-707: A Next-Gen PD-1/VEGF Bispecific for Cancer Treatment Pfizer Market Trend ASCO Cancer Pfizer acquires global rights to SSGJ-707, a PD-1/VEGF bispecific antibody from 3SBio, aiming to enhance its oncology pipeline with a novel mechanism and strong clinical potential.

< Pre 1...39 40 414243 44 45...87 Next >

Articles Archives

Hot Articles

Related Exhibition

All Categories

Agri & Industry Cosmetic Food History Laboratory

HOT Topics

Hot Articles